Top

Tag: Pharmaceuticals


FDA, Regulations

FDA Approves Botox Competitor That Lasts Longer

September 9, 2022

Via: Drugs.com

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades. Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is […]


Industry, Pharma

Pharma’s climate change vulnerability and opportunity

September 9, 2022

Via: Pharmaphorum

Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Rising global temperatures will, […]


Industry, Pharma

Now is the time for pharma to help solve bias in clinical trials

September 7, 2022

Via: Pharmaphorum

The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. […]


Mergers and Acquisitions

Aptar Pharma Acquires Metaphase Design Group

September 6, 2022

Via: Contract Pharma

Aptar Pharma, a leader in drug delivery and active material science solutions and services, has acquired Metaphase Design Group Inc., a leader in applying the science of human factors engineering and ergonomics to product design. The acquisition expands Aptar Pharma’s […]


Mergers and Acquisitions

Neurocrine Bio agrees $57m takeover of UK biotech Diurnal

August 30, 2022

Via: Pharmaphorum

The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday. Shares in the UK firm had leaped 132% to 26.1 pence at the time of writing […]


Manufacturing, Research and Development

ADHD Drug Adderall in Short Supply

August 29, 2022

Via: Drugs.com

Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is […]


FDA, Regulations

Thousands of U.S. Patients Got COVID Treatments Rejected as Useless by FDA

August 29, 2022

Via: Drugs.com

U.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and […]


Manufacturing, Mergers and Acquisitions, Research and Development

ElevateBio and the Univ. of Pittsburgh Enter Biomanufacturing Partnership

August 26, 2022

Via: Contract Pharma

ElevateBio and the University of Pittsburgh have entered into a long-term partnership to accelerate the development of cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing […]


Industry, Vaccines

AI-derived cancer vaccines: the pharmaphorum podcast

August 25, 2022

Via: Pharmaphorum

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. […]


Clinical Trials, Research and Development

To build diversity into clinical trials, collaborate at the community level

August 24, 2022

Via: Pharmaphorum

Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug Administration’s (FDA) draft guidance, Diversity Plans to Improve Enrollment of Participants […]


Industry, Vaccines

Next-generation RNA technologies: making longer-lasting drugs with a broader reach

August 23, 2022

Via: Biopharma Dive

The key ingredient in the coronavirus vaccines developed by Moderna and BioNTech doesn’t last very long. Once in the body, this messenger RNA, or mRNA, degrades within days. Still, that’s enough time for the vaccines to train the body to […]


Mergers and Acquisitions

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

August 23, 2022

Via: Biopharma Dive

Alcon has agreed to acquire Aerie Pharmaceuticals for about $770 million, betting its sprawling commercial presence can boost the uptake of the biotechnology company’s two glaucoma drugs. Alcon, the former eyecare business of Swiss pharmaceutical giant Novartis, will pay $15.25 […]


Clinical Trials, Research and Development

Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial

August 22, 2022

Via: Pharma Times

The phase 3 trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged one to 18. It is hoped that Epidiolex will ease symptoms associated with Doose syndrome (EMAS), a rarer type of […]


Industry, Vaccines

EU advisors back lower monkeypox jab dose to stretch supplies

August 22, 2022

Via: Pharmaphorum

The recommendation comes after a review of a clinical trial which found that delivering a smaller dose intradermally – just below the top layer of the skin – is as effective as giving the standard dose subcutaneously as recommended on […]


Industry, Vaccines

Pfizer told by FDA to test additional Paxlovid course in patients with COVID-19 rebound

August 22, 2022

Via: PMLiVE

The company must produce the initial results of a randomised controlled trial of a second course of the antiviral by 30 September next year, according to a letter from the regulator. The order follows reports of rebounding COVID-19 symptoms after […]


Industry, Vaccines

Powerful new antibody neutralizes all known SARS-CoV-2 variants

August 17, 2022

Via: World Pharma News

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially Omicron, have developed ways to evade the antibodies we make in response to vaccines. A new, broadly neutralizing […]


Industry, Vaccines

Biden Administration May Stop Buying COVID Vaccines, Treatments by Fall

August 17, 2022

Via: Drugs.com

The Biden Administration plans to stop buying COVID tests, vaccines and treatments as early as the fall, White House COVID-19 Response Coordinator Dr. Ashish Jha said Tuesday. Under that plan, those products would be provided through the regular health care […]


Industry, Vaccines

JCVI publishes advice on COVID-19 vaccines ahead of autumn booster campaign

August 17, 2022

Via: PMLiVE

For adults aged 18 years and above, the JCVI’s advised vaccines include Moderna’s mRNA (Spikevax) bivalent Omicron BA.1/original wild-type vaccine, as well as its mRNA (Spikevax) original wild-type vaccine. The Pfizer/BioNTech mRNA (Comirnaty) original wild-type vaccine is also advised, and […]


Industry, Vaccines

Merck makes circular RNA play with $3.5bn Orna alliance

August 16, 2022

Via: Pharmaphorum

It has also invested another $100 million in the three-year-old Cambridge, Massachusetts-based biotech, by participating in a $221 million Series B round. One of the unexpected consequences of the COVID-19 vaccine race was that some top-tier vaccine companies like Merck, […]


Industry, Vaccines

WHO releases interim statement on COVID-19 vaccination for children and adolescents

August 16, 2022

Via: PMLiVE

In the statement, it is concluded that before considering implementing primary vaccination series in children and adolescents, attaining high coverage of primary series – and booster doses as needed – in highest and high-priority-use groups must be pursued. WHO refers […]